Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mahler

Showing results (51-60 of 358) with videos related to

Pageof 36
Sort By:
Respiratory Medicine|October 21, 2005
Measuring the effects of COPD on the patientPaul Jones, Suzanne Lareau, Donald A Mahler
Chest|May 25, 2025
Selecting an Inhaled Delivery System in COPDDonald A Mahler, David M G Halpin
Annals of the American Thoracic Society|December 2, 2021
A Systematic Review of Published Algorithms for Selecting an Inhaled Delivery System in Chronic Obstructive Pulmonary DiseaseDavid M G Halpin, Donald A Mahler
BMJ Open Respiratory Research|April 16, 2024
Systematic review of the effects of patient errors using inhaled delivery systems on clinical outcomes in COPDDavid M G Halpin, Donald A Mahler
Chest|April 4, 2021
Peak Inspiratory Flow as a Predictive Therapeutic Biomarker in COPDDonald A Mahler, David M G Halpin
Annals of the American Thoracic Society|July 27, 2023
Personalizing Selection of Inhaled Delivery Systems in Chronic Obstructive Pulmonary DiseaseDonald A Mahler, David M G Halpin
Annals of Plastic Surgery|September 1, 1982
On the histroy of the free skin graftD J Hauben, A Baruchin, A Mahler
Chest|November 17, 2023
Consideration and Assessment of Patient Factors When Selecting an Inhaled Delivery System in COPDDonald A Mahler, David M G Halpin
International Journal of Chronic Obstructive Pulmonary Disease|January 8, 2020
Revefenacin: A Once-Daily, Long-Acting Bronchodilator For Nebulized Treatment Of COPDJames F Donohue, Donald A Mahler, Sanjay Sethi
Neuropeptides|April 1, 1983
Further biochemical characterization of the polyneuropeptide h3 recently isolated from human brain material, and its identification in human liverF Bollengier, A Foriers, M Lauwereys, et al.
Pageof 36

Showing results (51-60 of 358) with videos related to

Sort By:
Pageof 36
Respiratory Medicine|October 21, 2005
Measuring the effects of COPD on the patientPaul Jones, Suzanne Lareau, Donald A Mahler
Chest|May 25, 2025
Selecting an Inhaled Delivery System in COPDDonald A Mahler, David M G Halpin
Annals of the American Thoracic Society|December 2, 2021
A Systematic Review of Published Algorithms for Selecting an Inhaled Delivery System in Chronic Obstructive Pulmonary DiseaseDavid M G Halpin, Donald A Mahler
BMJ Open Respiratory Research|April 16, 2024
Systematic review of the effects of patient errors using inhaled delivery systems on clinical outcomes in COPDDavid M G Halpin, Donald A Mahler
Chest|April 4, 2021
Peak Inspiratory Flow as a Predictive Therapeutic Biomarker in COPDDonald A Mahler, David M G Halpin
Annals of the American Thoracic Society|July 27, 2023
Personalizing Selection of Inhaled Delivery Systems in Chronic Obstructive Pulmonary DiseaseDonald A Mahler, David M G Halpin
Annals of Plastic Surgery|September 1, 1982
On the histroy of the free skin graftD J Hauben, A Baruchin, A Mahler
Chest|November 17, 2023
Consideration and Assessment of Patient Factors When Selecting an Inhaled Delivery System in COPDDonald A Mahler, David M G Halpin
International Journal of Chronic Obstructive Pulmonary Disease|January 8, 2020
Revefenacin: A Once-Daily, Long-Acting Bronchodilator For Nebulized Treatment Of COPDJames F Donohue, Donald A Mahler, Sanjay Sethi
Neuropeptides|April 1, 1983
Further biochemical characterization of the polyneuropeptide h3 recently isolated from human brain material, and its identification in human liverF Bollengier, A Foriers, M Lauwereys, et al.
Pageof 36